Skip to main content
PMC home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1983;94:141–153.

Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortality.

J J Sayen, R B Singer, G Peirce, O Horwitz
PMCID: PMC2279570  PMID: 7186227

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEARD O. W., HIPP H. R., ROBINS M., TAYLOR J. S., EBERT R. V., BERAN L. G. Initial myocardial infarction among 503 veterans: five-year survival. Am J Med. 1960 Jun;28:871–883. doi: 10.1016/0002-9343(60)90196-0. [DOI] [PubMed] [Google Scholar]
  2. Bell W. R., Royall R. M. Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med. 1980 Oct 16;303(16):902–907. doi: 10.1056/NEJM198010163031602. [DOI] [PubMed] [Google Scholar]
  3. Castellot J. J., Jr, Addonizio M. L., Rosenberg R., Karnovsky M. J. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol. 1981 Aug;90(2):372–379. doi: 10.1083/jcb.90.2.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chong B. H., Pitney W. R., Castaldi P. A. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation. Lancet. 1982 Dec 4;2(8310):1246–1249. doi: 10.1016/s0140-6736(82)90106-4. [DOI] [PubMed] [Google Scholar]
  5. DOUGHERTY T. F., DOLOWITZ D. A. PHYSIOLOGIC ACTIONS OF HEPARIN NOT RELATED TO BLOOD CLOTTING. Am J Cardiol. 1964 Jul;14:18–24. doi: 10.1016/0002-9149(64)90099-2. [DOI] [PubMed] [Google Scholar]
  6. Engelberg H. Heparin and atherosclerosis. A review of old and recent findings. Am Heart J. 1980 Mar;99(3):359–372. doi: 10.1016/0002-8703(80)90352-x. [DOI] [PubMed] [Google Scholar]
  7. Engleberg H. The effect of heparin on oxygen transport from blood to tissues. Adv Exp Med Biol. 1975;52:299–306. [PubMed] [Google Scholar]
  8. GRIFFITH G. C., ZINN W. J., ENGELBERG H., DOOLEY J. V., ANDERSON R. Heparin versus heparin-bishydroxycoumarin anticoagulant therapy: comparison in patients with acute complicated myocardial infarction. JAMA. 1960 Oct 29;174:1157–1160. doi: 10.1001/jama.1960.03030090013003. [DOI] [PubMed] [Google Scholar]
  9. Gitel S. N., Wessler S. The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits: clinical implications. J Lab Clin Med. 1979 Sep;94(3):481–488. [PubMed] [Google Scholar]
  10. Guyton J. R., Rosenberg R. D., Clowes A. W., Karnovsky M. J. Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res. 1980 May;46(5):625–634. doi: 10.1161/01.res.46.5.625. [DOI] [PubMed] [Google Scholar]
  11. Hiebert L. M., Jaques L. B. The observation of heparin on endothelium after injection. Thromb Res. 1976 Feb;8(2):195–204. doi: 10.1016/0049-3848(76)90262-0. [DOI] [PubMed] [Google Scholar]
  12. Hull R., Delmore T., Carter C., Hirsh J., Genton E., Gent M., Turpie G., McLaughlin D. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med. 1982 Jan 28;306(4):189–194. doi: 10.1056/NEJM198201283060401. [DOI] [PubMed] [Google Scholar]
  13. Jaques L. B. Heparins--anionic polyelectrolyte drugs. Pharmacol Rev. 1979 Jun;31(2):99–166. [PubMed] [Google Scholar]
  14. KUO P. T., JOYNER C. R., Jr Effect of heparin on lipemia-induced angina pectoris. J Am Med Assoc. 1957 Mar 2;163(9):727–731. doi: 10.1001/jama.1957.02970440023007. [DOI] [PubMed] [Google Scholar]
  15. Leehey D., Gantt C., Lim V. Heparin-induced hypoaldosteronism. Report of a case. JAMA. 1981 Nov 13;246(19):2189–2190. [PubMed] [Google Scholar]
  16. Librach G., Schadel M., Seltzer M., Hart A., Yellin N. Immediate and long-term prognosis of acute myocardial infarction in the aged. J Chronic Dis. 1976 Aug;29(8):483–495. doi: 10.1016/0021-9681(76)90013-8. [DOI] [PubMed] [Google Scholar]
  17. Mitchell J. R. Anticoagulants in coronary heart disease--retrospect and prospect. Lancet. 1981 Jan 31;1(8214):257–262. doi: 10.1016/s0140-6736(81)92095-x. [DOI] [PubMed] [Google Scholar]
  18. Negus D., Pinto D. J., Slack W. W. Effect of small doses of heparin on platelet adhesiveness and lipoprotein-lipase activity before and after surgery. Lancet. 1971 Jun 12;1(7711):1202–1204. doi: 10.1016/s0140-6736(71)91716-8. [DOI] [PubMed] [Google Scholar]
  19. Rosenberg R. D. Heparin, antithrombin, and abnormal clotting. Annu Rev Med. 1978;29:367–378. doi: 10.1146/annurev.me.29.020178.002055. [DOI] [PubMed] [Google Scholar]
  20. Rosenberg R. D., Jordan R. E., Favreau L. V., Lam L. H. Highly active heparin species with multiple binding sites for antithrombin. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1319–1324. doi: 10.1016/0006-291x(79)90260-2. [DOI] [PubMed] [Google Scholar]
  21. Ruggiero H. A., Castellanos H., Caprissi L. F., Caprissi E. S. Heparin effect on blood viscosity. Clin Cardiol. 1982 Mar;5(3):215–218. doi: 10.1002/clc.4960050303. [DOI] [PubMed] [Google Scholar]
  22. Shelley W. B., Saÿen J. J. Heparin necrosis: an anticoagulant-induced cutaneous infarct. J Am Acad Dermatol. 1982 Nov;7(5):674–677. doi: 10.1016/s0190-9622(82)70150-1. [DOI] [PubMed] [Google Scholar]
  23. Szklo M., Tonascia J. A., Goldberg R., Kennedy H. L. Additional data favoring use of anticoagulant therapy in myocardial infarction. A population-based study. JAMA. 1979 Sep 21;242(12):1261–1264. [PubMed] [Google Scholar]
  24. Telford A. M., Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet. 1981 Jun 6;1(8232):1225–1228. doi: 10.1016/s0140-6736(81)92399-0. [DOI] [PubMed] [Google Scholar]
  25. Weinblatt E., Shapiro S., Frank C. W. Prognosis of women with newly diagnosed coronary heart disease--a comparison with course of disease among men. Am J Public Health. 1973 Jul;63(7):577–593. doi: 10.2105/ajph.63.7.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Weinblatt E., Shapiro S., Frank C. W., Sager R. V. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health. 1968 Aug;58(8):1329–1347. doi: 10.2105/ajph.58.8.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES